Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketamine for relapse prevention in recurrent depressive disorder
2015-002020-37Phase 2Terminated
- Sponsor
- St Patrick's Mental Health Services
- Start
- Aug 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial in recurrent depressive disorder (RDD) and major depressive disorder (MDD) comparing Ketalar arm with Hypnovel control arm (2 arms). Primary endpoint: Primary trial-process outcome. Started Aug 2015; status: terminated.
02
Drugs
ketaminemidazolam
03
Conditions
recurrent depressive disorder (RDD)major depressive disorder (MDD)
Beyond the preview
Go deeper on 2015-002020-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-002020-37.